The Innovation to Commercialization Pipeline (ICP) program, co-led by Forward BIOLABS and BioForward, is designed to support emerging Wisconsin biohealth companies in navigating the complex journey from discovery to market.

The ICP program aims to overcome critical commercialization barriers and capital-access gaps by providing emerging companies with targeted funding to obtain the tools, resources, and vital support they need to scale. Eligible companies can apply for tailored, company-specific support designed to accelerate their commercialization journey, empowering them to reduce scaling risks and attract future investment.

TYPES OF PROJECTS FUNDED
Awards are intended to support specific commercialization activities that directly advance defined milestones and bring your company to the next growth phase.

Applicants can apply for, but are not limited to, the following projects:

• Assistance in achieving a commercial milestone
• Business development resources
• Contracted services (e.g., CRO, CDMO, CMO, etc.)
• Fundraising assistance (e.g., conferences, travel expenses, etc.)
• Legal support (e.g., assistance with patents, IP, corporate, etc.)
• Marketing resources
• Product development, technology de-risking, or access to scientific equipment
• Regulatory services (e.g., regulatory consulting, pathway strategies, FDA meeting preparation & submissions, regulatory gap assessment, etc.)

Applications open Oct. 13, due by Nov. 14

More information and application